Morrone Louis H. 4
4 · ABBOTT LABORATORIES · Filed Jul 5, 2023
Insider Transaction Report
Form 4
Morrone Louis H.
EXECUTIVE VICE PRESIDENT
Transactions
- Award
Common shares without par value
2023-06-30+1,815→ 55,471 total - Tax Payment
Common shares without par value
2023-07-01$109.02/sh−556$60,615→ 54,915 total - Award
Option (right to buy)
2023-06-30+7,100→ 7,100 totalExercise: $108.52From: 2024-06-30Exp: 2033-06-29→ Common Shares (7,100 underlying)
Holdings
- 2,481(indirect: By Trust)
Common shares without par value
Footnotes (3)
- [F1]These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.
- [F2]Balance in the Abbott Laboratories Stock Retirement Trust as of June 30, 2023.
- [F3]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 2,366 on June 30, 2024, 2,367 on June 30, 2025, and 2,367 on June 30, 2026.